预防卵巢癌项目:用互补招募方式识别卵巢癌高危女性
加拿大安大略省通过外展宣传自我报名和直接招募已故高级别浆液性卵巢癌(HGSOC)患者的一级亲属两种方式,为564名女性提供基因咨询与多基因面板检测。风险评估基因致病变异率在一级亲属确诊HGSOC<60岁时最高(9.4% vs ≥60岁3.9%,p=0.0160);外展组检测接受率(97% vs 89%,p=0.0036)和研究完成率(95% vs 87%,p=0.0062)更高。
要点
- 一级亲属确诊HGSOC<60岁时致病变异率显著更高(9.4% vs 3.9%)
- 外展自我报名组的基因检测接受率和研究完成率高于直接招募组
- 建议安大略省基因检测标准纳入一级亲属<60岁确诊HGSOC的个体
核心结论
- 总体致病变异率低于预期,但证据支持将一级亲属<60岁确诊HGSOC的个体纳入安大略省基因检测标准。
研究设计与样本
- 2015年5月至2019年9月在加拿大安大略省开展,共564名女性入组,其中外展宣传自我报名473人、直接招募91人;提供基因咨询与多基因面板检测并评估两种招募方式。
主要发现
- 入组时平均年龄52岁,96%不符合省级检测标准;528人来自458个家庭获得基因结果。
- 一级亲属确诊HGSOC<60岁者卵巢癌风险基因致病变异率为9.4%,≥60岁者为3.9%(p=0.0160)。
- 外展组与直接招募组致病变异率相似,但外展组检测接受率97% vs 89%(p=0.0036)、研究完成率95% vs 87%(p=0.0062)更高。
关键数值与推荐
- 一级亲属确诊HGSOC<60岁者致病变异率9.4%,≥60岁者3.9%(p=0.0160)。
- 外展组检测接受率97% vs 直接招募组89%(p=0.0036),研究完成率95% vs 87%(p=0.0062)。
临床怎么用
- 对一级亲属<60岁确诊HGSOC且未做过基因检测的女性,应主动提供基因咨询与多基因面板检测。
- 外展宣传自我报名可提高基因检测接受率和研究完成率,可作为招募高危女性的有效方式。
局限性
- 总体致病变异率低于预期,可能影响对获益的解读。
- 两种招募方式为非随机比较,检测接受率与完成率差异可能受选择偏倚影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Up to 20% of high-grade serous ovarian carcinomas (HGSOC) are hereditary; however, historical uptake of genetic testing is low. We used a unique combination of approaches to identify women in Ontario, Canada, with a first-degree relative (FDR) who died from HGSOC without prior genetic testing, and offer them multi-gene panel testing. METHODS: From May 2015-Sept 2019, genetic counseling and testing was provided to eligible participants. Two recruitment strategies were employed, including self-identification in response to an outreach campaign and direct targeting of FDRs of deceased HGSOC patients treated at our institution. The rate of pathogenic variants (PV) in established/potential ovarian cancer risk genes and the benefits/challenges of each approach were assessed. RESULTS: A total of 564 women enrolled in response to our outreach campaign (n = 473) or direct recruitment (n = 91). Mean age at consent was 52 years and 96% did not meet provincial testing criteria. Genetic results were provided to 528 individuals from 458 families. The rate of PVs in ovarian cancer risk genes was highest when FDRs were diagnosed with HGSOC <60 years (9.4% vs. 3.9% ≥ 60y, p = 0.0160). Participants in the outreach vs. direct recruitment cohort had a similar rate of PVs; however, uptake of genetic testing (97% vs. 89%; p = 0.0036) and study completion (95% vs. 87%; p = 0.0062) rates were higher in the former. Eleven participants with pathogenic variants have completed risk-reducing gynecologic surgery, with one stage I HGSOC and two breast cancers identified. CONCLUSION: Overall PV rates in this large cohort were lower than expected; however, we provide evidence that genetic testing criteria in Ontario should include individuals with a deceased FDR diagnosed with HGSOC <60 years of age.
引用
- Tone AA, McCuaig JM, Ricker N, et al. The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches. Gynecol Oncol. 2021. PMID: 33858678. doi:10.1016/j.ygyno.2021.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。